Literature DB >> 11146153

Drug resistance gene transfer: Stem cell protection and therapeutic efficacy.

S L Gerson1.   

Abstract

Mesh：

Year:  2000        PMID： 11146153     DOI： 10.1016/s0301-472x(00)00548-8

Source DB:  PubMed          Journal:  Exp Hematol        ISSN： 0301-472X            Impact factor:   3.084


× No keyword cloud information.
  4 in total

1.  Future alternative therapies for β-thalassemia.

Authors:  Stefano Rivella; Eliezer Rachmilewitz
Journal:  Expert Rev Hematol       Date:  2009-12-01       Impact factor: 2.929

2.  Amelioration of murine beta-thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both gamma-globin and the MGMT drug-resistance gene.

Authors:  Huifen Zhao; Tamara I Pestina; Md Nasimuzzaman; Perdeep Mehta; Phillip W Hargrove; Derek A Persons
Journal:  Blood       Date:  2009-04-13       Impact factor: 22.113

3.  Gene therapy in thalassemia and hemoglobinopathies.

Authors:  Laura Breda; Roberto Gambari; Stefano Rivella
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-11-13       Impact factor: 2.576

4.  Recent advances in gene therapy for thalassemia.

Authors:  J V Raja; M A Rachchh; R H Gokani
Journal:  J Pharm Bioallied Sci       Date:  2012-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.